We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMBA
2801
DELISTED
Jamba, Inc.
JMBA
$162K ﹤0.01%
13,125
+100
+0.8% +$1.27K
VOXX
2802
DELISTED
VOXX International Corporation Class A
VOXX
$161K ﹤0.01%
36,089
+2,585
+8% +$11.3K
ALR
2803
DELISTED
AlerisLife Inc
ALR
$161K ﹤0.01%
7,020
+837
+14% +$20.5K
FMSA
2804
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$161K ﹤0.01%
64,092
+680
+1% +$1.45K
NWHM
2805
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$160K ﹤0.01%
13,011
+2,765
+27% +$27.8K
ARLZ
2806
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$160K ﹤0.01%
+44,973
New +$232K
NATR icon
2807
Nature's Sunshine
NATR
$360M
$159K ﹤0.01%
16,519
+1,470
+10% +$12.7K
RNWK
2808
DELISTED
RealNetworks Inc
RNWK
$159K ﹤0.01%
39,214
+3,245
+9% +$12.4K
SRNE
2809
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$158K ﹤0.01%
29,400
+230
+0.8% +$1.34K
NAVB
2810
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$155K ﹤0.01%
8,197
+173
+2% +$3.33K
GNCA
2811
DELISTED
Genocea Biosciences, Inc.
GNCA
$154K ﹤0.01%
2,492
GNRT
2812
DELISTED
Gener8 Maritime, Inc.
GNRT
$154K ﹤0.01%
21,785
+2,280
+12% +$14.7K
ARDX icon
2813
Ardelyx
ARDX
$1.24B
$153K ﹤0.01%
19,686
+4,100
+26% +$40.4K
PFNX
2814
DELISTED
Pfenex Inc.
PFNX
$153K ﹤0.01%
15,609
+300
+2% +$2.62K
BDSI
2815
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$153K ﹤0.01%
47,255
+750
+2% +$2.77K
NDLS icon
2816
Noodles & Co
NDLS
$106M
$152K ﹤0.01%
1,598
+60
+4% +$5.8K
SIOX
2817
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$152K ﹤0.01%
1,659
+96
+6% +$10.2K
ETSY icon
2818
Etsy
ETSY
$8.2B
$151K ﹤0.01%
17,382
+175
+1% +$1.4K
AXAS
2819
DELISTED
Abraxas Petroleum Corp
AXAS
$150K ﹤0.01%
7,421
+662
+10% +$12.9K
CRCM
2820
DELISTED
CARE.COM, INC.
CRCM
$150K ﹤0.01%
24,392
+2,540
+12% +$15.4K
AMRC icon
2821
Ameresco
AMRC
$1.48B
$148K ﹤0.01%
30,984
+2,820
+10% +$14.4K
NM
2822
DELISTED
Navios Maritime Holdings Inc.
NM
$148K ﹤0.01%
13,076
+832
+7% +$8.68K
FOMX
2823
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$148K ﹤0.01%
22,719
BOX icon
2824
Box
BOX
$4.4B
$145K ﹤0.01%
11,849
FRPT icon
2825
Freshpet
FRPT
$3.07B
$145K ﹤0.01%
19,840

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.